Mayo Clinic proceedings
-
Mayo Clinic proceedings · Dec 2023
Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves.
To compare all-cause mortality and thromboembolic events in patients undergoing surgical aortic valve replacement (sAVR) receiving anticoagulation with warfarin versus patients with no systemic anticoagulation. ⋯ During the prescription coverage period, warfarin use after bioprosthetic sAVR was associated with lower all-cause mortality and decreased risk of thromboembolism compared with not receiving warfarin. However, warfarin use was associated with an increased risk of major bleeding events.